Test Price
950 AED✅ Home Collection Available
Hirsutism Panel in UAE: Comprehensive Androgen & Hormone Profile | 950 AED
Executive Summary & Core Metrics
Executive Summary
The Hirsutism Panel is a definitive endocrine evaluation measuring six key androgens and binding proteins — Total Testosterone, Free Testosterone, DHEA-Sulfate, Androstenedione, 17-OH Progesterone, and Sex Hormone Binding Globulin (SHBG) — to identify the biochemical root cause of excess hair growth in women. This panel differentiates between ovarian, adrenal, and idiopathic sources of hyperandrogenism, serving as the essential laboratory foundation for diagnosing Polycystic Ovary Syndrome (PCOS), Non-Classical Congenital Adrenal Hyperplasia (NCCAH), and androgen-secreting neoplasms.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy service.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by certified clinical advisors.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Hirsutism Panel is a comprehensive endocrine evaluation measuring six key androgens and binding proteins — Total Testosterone, Free Testosterone, DHEA-Sulfate, Androstenedione, 17-OH Progesterone, and Sex Hormone Binding Globulin (SHBG) — to identify the biochemical root cause of excess hair growth in women. This panel differentiates between ovarian, adrenal, and idiopathic sources of hyperandrogenism, serving as the definitive laboratory foundation for diagnosing conditions such as Polycystic Ovary Syndrome (PCOS), Non-Classical Congenital Adrenal Hyperplasia (NCCAH), and androgen-secreting neoplasms.
This panel utilizes Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) and Radioimmunoassay (RIA), the internationally accepted gold-standard methodologies for steroid hormone quantification, ensuring unparalleled accuracy, specificity, and sensitivity in the femtomolar to nanomolar concentration range.
Pre-Test Preparation & Collection Protocol
Specimen requires 5 mL serum collected in Serum Separator Tubes (SST). Early morning collection (7:00 AM - 9:00 AM) is strongly preferred to capture peak androgen levels and minimize circadian variability. Recommended collection window for females is Day 4 through Day 10 of the menstrual cycle. Patients must discontinue biotin supplementation 72 hours prior and avoid all DHEA or prohormone supplements for a minimum of 7 days before testing. Specimens must be shipped refrigerated (2-8°C) or frozen (-20°C) via ISO-certified cold-chain logistics to maintain analyte stability.
Continue all prescribed medications, including oral contraceptives, anti-androgens, metformin, or corticosteroid therapy, exactly as directed by your physician unless explicitly instructed otherwise. Accurate age and sex notation on the test requisition form is mandatory, as pediatric and postmenopausal reference ranges differ significantly from reproductive-age norms.
Our Panel vs. Standard Single-Analyte Testing
| Parameter | Our Hirsutism Panel | Standard Single-Analyte Test |
|---|---|---|
| Precision | LC-MS/MS & RIA — gold-standard tandem methodology | Immunoassay-only; cross-reactivity risk |
| Methodology | Liquid Chromatography-Tandem Mass Spectrometry + Radioimmunoassay | Single-platform chemiluminescent immunoassay (CLIA) |
| Speed (TAT) | Sample Mon/Thu by 9 AM; Report Wed/Sat | 5-7 business days; no defined batch schedule |
| Analytes Covered | 6 analytes: Total T, Free T, DHEA-S, Androstenedione, 17-OHP, SHBG | 1-2 analytes; incomplete androgen profile |
| Clinical Utility | Full differential diagnosis capability | Screening only; requires reflex testing |
Physician Insight & Safety Protocols
“As a clinician managing endocrine disorders, I stress that interpreting this panel requires correlating the biochemical profile with the patient’s menstrual cycle phase, Ferriman-Gallwey score, and ovarian imaging. Isolated androgen elevations can be misleading; a pattern-based approach differentiating PCOS from NCCAH or adrenal tumors is essential for targeted therapy. This panel provides the metabolic map necessary to distinguish functional ovarian hyperandrogenism from enzymatic adrenal blocks, ensuring that pharmacologic intervention is precisely aligned with the underlying pathophysiology.”
— Dr. Ajay Singh, General Practitioner, DHA License: 36234132
Critical Pre-Test Advisory
Medication Stability Warning
Do not discontinue any prescribed medication, including oral contraceptives, anti-androgens, metformin, or corticosteroid therapy, without explicit consultation with your treating physician. Abrupt cessation of hormonal or endocrine medications may precipitate acute adrenal insufficiency, withdrawal bleeding, or metabolic destabilization. This panel is a diagnostic monitoring tool — it does not replace clinical judgment or prescribed therapeutic regimens.
Exclusion Criteria & Emergency Red Flags
Do NOT proceed with home collection and seek immediate emergency care if the patient is experiencing:
- Acute abdominal or pelvic pain with nausea, vomiting, or hemodynamic instability — may indicate ovarian torsion, ruptured ovarian cyst, or ectopic pregnancy requiring urgent surgical evaluation.
- Sudden-onset virilization (deepening voice, clitoromegaly, male-pattern baldness, severe acne fulminans) developing over weeks to months — suggests an androgen-secreting adrenal or ovarian neoplasm demanding immediate oncologic workup.
- Syncope, hypotension, or severe electrolyte disturbances — may signify adrenal crisis, especially in patients on chronic corticosteroid therapy who have tapered or missed doses.
- Known pregnancy — hormonal reference ranges are altered; testing should be deferred until postpartum unless specifically ordered by a maternal-fetal medicine specialist.
- Active febrile illness or acute infection — may transiently alter cortisol and androgen levels, compromising diagnostic accuracy.
Patient FAQ & Clinical Guidance
1. What does the Hirsutism Panel measure, and why is it ordered?
The Hirsutism Panel measures six critical androgens and binding proteins to pinpoint whether excess hair growth originates from ovarian dysfunction, adrenal gland overproduction, or peripheral tissue conversion. Physicians order this panel when a female patient presents with hirsutism scoring above 8 on the Ferriman-Gallwey scale, accompanied by oligomenorrhea, acne, or alopecia — it is the first-line biochemical tool to differentiate PCOS from Non-Classical Congenital Adrenal Hyperplasia, androgen-secreting tumors, or idiopathic hirsutism before initiating targeted pharmacotherapy.
2. How should I prepare for the Hirsutism Panel blood collection?
You must schedule your blood draw in the early morning between 7:00 AM and 9:00 AM, ideally between Day 4 and Day 10 of your menstrual cycle, while fasting overnight. Discontinue biotin supplements 72 hours prior and avoid all DHEA or prohormone supplements for at least 7 days. Continue all prescribed medications — including oral contraceptives, spironolactone, and metformin — exactly as directed by your physician. Our DHA-licensed phlebotomist will collect 5 mL of blood using two serum separator tubes, and the sample will be transported under strict cold-chain conditions to maintain analyte stability until LC-MS/MS and RIA processing at our ISO-accredited laboratory.
3. What do abnormal results mean, and what happens after I receive my report?
Abnormal results indicate an elevation in one or more androgens that maps to a specific endocrine disorder — elevated free testosterone with high LH-to-FSH ratio strongly suggests PCOS, while isolated markedly elevated 17-OH Progesterone points toward Non-Classical Congenital Adrenal Hyperplasia requiring genetic confirmation. After your report is released on the scheduled Wednesday or Saturday, you will receive a telephonic clinical guidance session to explain the biochemical findings in plain language. Your results must be reviewed by an endocrinologist who will correlate the laboratory data with your clinical presentation, imaging studies, and family history before formulating a personalized treatment plan that may include anti-androgen therapy, insulin-sensitizing agents, or further dynamic endocrine testing.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Accreditation
DNA Labs UAE operates this laboratory service in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring strict patient data privacy and confidentiality. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
ISO 9001:2015 Certified | Certificate: INT/EGQ/2509DA/3139 | Facility License: 1143
DHA-Accredited Laboratory | Methodology: LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) & RIA (Radioimmunoassay)
Home Collection Hours: 8:00 AM – 11:00 PM daily | WhatsApp Support: +971 54 548 8731
Clinical & Logistical Metadata
| Test Name | Hirsutism Panel (Total & Free Testosterone, DHEA-S, Androstenedione, 17-OHP, SHBG) |
| Price (AED) | 950 AED |
| Turnaround Time | Samples Mon/Thu by 9 AM; Report Wed/Sat |
| Sample Type / Matrix | 5 mL Serum in SST (Minimum 4 mL) |
| Methodology Used | LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) & RIA (Radioimmunoassay) |
| ICD-10-CM Code | L68.0 (Hirsutism), E28.1 (Androgen excess), E25.9 (Adrenogenital disorder) |
| LOINC Code | 10513-1 (Testosterone Free/Total Panel), 17853-2 (DHEA-S), 20570-3 (17-OHP) |
| DHA License & Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians